CEO
[ Seong Hwan Kim CEO, MADI ]
CEO Message
We create solutions that deeply understand
and address the real needs of healthcare settings.
As an orthopedic surgeon who has treated countless patients, I have witnessed the
fundamental dilemmas inherent in clinical trials. Some patients are assigned to
control groups and miss treatment opportunities to validate new therapies, while
enormous costs and time delays impede drug development.
MADI aims to solve these problems through AI technology. By creating Digital Twins using generative AI to generate virtual control groups, we are realizing ethical clinical trials where every patient can receive treatment.br We are also dramatically reducing the duration and cost of clinical trials, enabling innovative treatments to reach more patients faster.
The convergence of clinical experience and cutting-edge AI technology is MADI's unique competitive advantage. We don't just develop technology - we create solutions that deeply understand and address the real needs of healthcare settings.
I look forward to welcoming passionate talents who will join MADI in transforming the paradigm of clinical trials and shaping the future of medical AI.
Your skills and passion can become hope for countless patients.
Thank you.
CEO, MADI
Education
Career & Training
Awards